Semantic search

Human (Homo sapiens)

• 10773-110F8
• 10813-111B3 (normal embryonic palatal mesenchymal cell line:HEPM)
• 11219-116B4 (Mesenchymal Stem Cells - Vertebral, donor1)
• 11248-116E6 (Anulus Pulposus Cell, donor1)
• 11252-116F1 (Nucleus Pulposus Cell, donor1)
• 11293-117A6 (Canine Mesenchymal stem cells - bone marrow derived, donor1)
• 11294-117A7 (Chicken Mesenchymal stem cells - bone marrow derived, donor1)
• 11296-117A9 (Rat Mesenchymal stem cells - bone marrow derived, donor1)
• 11370-118A2 (Canine Mesenchymal stem cells - bone marrow derived, donor2)
• 11373-118A5 (Rat Mesenchymal stem cells - bone marrow derived, donor2)
• 11409-118E5 (Nucleus Pulposus Cell, donor2)
• 11442-118I2 (Canine Mesenchymal stem cells - bone marrow derived, donor3)
• 11445-118I5 (Rat Mesenchymal stem cells - bone marrow derived, donor3)
• 11462-119B4 (Nucleus Pulposus Cell, donor3)
• 11463-119B5 (Anulus Pulposus Cell, donor2)
• 11464-119B6 (Mesenchymal Stem Cells - bone marrow, donor4)
• 11536-120A6 (Mesenchymal Stem Cells - bone marrow, donor1)
• 11616-122A5 (Mesenchymal Stem Cells - bone marrow, donor2)
• 11640-122D2 (Mouse Mesenchymal stem cells - bone marrow derived, donor3)
• 11697-123A5 (Mesenchymal Stem Cells - bone marrow, donor3)
• 11717-123C7 (Mouse Mesenchymal stem cells - bone marrow derived, donor1)
• 11735-123E7 (Mouse Mesenchymal stem cells - bone marrow derived, donor2)
• 11750-123G4 (mesenchymal precursor cell - bone marrow, donor1)
• 11751-123G5 (mesenchymal precursor cell - bone marrow, donor2)
• 11774-124A1 (CD41+ megakaryocyte cancer, donor1)
• 11775-124A2 (CD41+ megakaryocyte control, donor1)
• 11776-124A3 (CD41+ megakaryocyte cancer, donor2)
• 11777-124A4 (CD41+ megakaryocyte control, donor2)
• 11778-124A5 (CD41+ megakaryocyte cancer, donor3)
• 11779-124A6 (CD41+ megakaryocyte control, donor3)
• 11840-124H4 (mesenchymal precursor cell - bone marrow, donor3)
• 11929-125I3 (Mallassez-derived cells, donor2)
• 11930-125I4 (Mallassez-derived cells, donor3)
• 11956-126C3 (hematopoietic stem cell, bone marrow derived, embryo E19.5)
• 11957-126C4 (hematopoietic stem cell, bone marrow derived, newborn 2-3months)
• 11958-126C5 (hematopoietic stem cell, bone marrow derived, adult 2years)
• 12123-128C8 (granulocyte macrophage progenitor GMP, biol_rep1)
• 12126-128D2 (granulocyte macrophage progenitor GMP, biol_rep2)
• 12129-128D5 (granulocyte macrophage progenitor GMP, biol_rep3)
• 12131-128D7 (granulocyte macrophage progenitor, donor1)
• 12135-128E2 (granulocyte macrophage progenitor, donor2)
• 12139-128E6 (granulocyte macrophage progenitor, donor3)
• 12142-128E9 (Mallassez-derived cells, donor1 (MZH3))
• 12157-128G6 (Sox2+ Supporting cells - organ of corti, pool1)
• 12158-128G7 (Atoh+ Inner ear hair cells - organ of corti, pool1)
• 12215-129E1 (Inner ear stem cells, 1st generation stem cells, pool1)
• 12216-129E2 (Inner ear stem cells, 4th generation stem cells, pool1)
• 12217-129E3 (Inner ear stem cells, differentiation, day03, pool1)
• 12218-129E4 (Inner ear stem cells, differentiation, day10, pool1)
• 12224-129F1 (CD133+ stem cells - adult bone marrow derived, pool1)
• 12662-134I7 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12663-134I8 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12664-134I9 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12665-135A1 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12666-135A2 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12667-135A3 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12668-135A4 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12669-135A5 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12670-135A6 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12671-135A7 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12672-135A8 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12673-135A9 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12674-135B1 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12675-135B2 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12676-135B3 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12677-135B4 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12678-135B5 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12679-135B6 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12680-135B7
• 12681-135B8
• 12682-135B9
• 12683-135C1
• 12684-135C2
• 12685-135C3
• 12686-135C4
• 12687-135C5
• 12688-135C6
• 12689-135C7
• 12690-135C8
• 12691-135C9
• 12692-135D1
• 12693-135D2
• 12694-135D3
• 12695-135D4
• 12696-135D5
• 12697-135D6 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17))
• 12760-136B6 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12761-136B7 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12762-136B8 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12763-136B9 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12764-136C1 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12765-136C2 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12766-136C3 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12767-136C4 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12768-136C5 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12769-136C6 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12770-136C7 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12771-136C8 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12772-136C9 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12773-136D1 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12774-136D2 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12775-136D3 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12776-136D4 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12777-136D5 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12778-136D6
• 12779-136D7
• 12780-136D8
• 12781-136D9
• 12782-136E1
• 12783-136E2
• 12784-136E3
• 12785-136E4
• 12786-136E5
• 12787-136E6
• 12788-136E7
• 12789-136E8
• 12790-136E9
• 12791-136F1
• 12792-136F2
• 12793-136F3
• 12794-136F4
• 12795-136F5 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17))
• 12858-137D5 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12859-137D6 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12860-137D7 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12861-137D8 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12862-137D9 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12863-137E1 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12864-137E2 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12865-137E3 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12866-137E4 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12867-137E5 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12868-137E6 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12869-137E7 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12870-137E8 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12871-137E9 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12872-137F1 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12873-137F2 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12874-137F3 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12875-137F4 (Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification)
• 12876-137F5
• 12877-137F6
• 12878-137F7
• 12879-137F8
• 12880-137F9
• 12881-137G1
• 12882-137G2
• 12883-137G3
• 12884-137G4
• 12885-137G5
• 12886-137G6
• 12887-137G7
• 12888-137G8
• 12889-137G9
• 12890-137H1
• 12891-137H2
• 12892-137H3
• 12893-137H4 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17))
• 1350-25C3 (bone (os femoris), neonate N20)
• 1525-43A6 (bone (os femoris), neonate N16)
• 1985-43F5 (bone (os femoris), neonate N02)
• 2171-50H8 (macrophage, bone marrow derived)
• 2379-69A1 (osteoclast, bone marrow derived)
• 3560-170A1 (macrophage, bone marrow derived)
• 3632-171A1 (macrophage, bone marrow derived)
• 56-12G2 (bone (os femoris), adult)